Gilead Sciences (NASDAQ:GILD) and Johnson & Johnson (NYSE:JNJ) have competed against each other for years in the HIV market. The clear winner in that battle has been Gilead. J&J could also soon have Gilead nipping at its heels in the immunology …
See Original Article

Sacramento, Calif. (AP) — California will ban the sale and manufacture of new fur products and bar most animals from circus performances under a
See Original Article

Revolut Ltd. has hired JPMorgan Chase & Co. to raise $1.5 billion in debt and equity, Sky News reported, without saying where it got the information.
See Original Article

The state of Michigan has pulled $600 million of its pension fund from wealth management company Fisher Investments after the company’s founder and CEO Ken Fisher made sexist comments at a summit in San Francisco this week. At the Tiburon …
See Original Article

Mediobanca SpA's second-biggest shareholder, Vincent Bollore, threw his support behind the Italian investment bank's chief executive officer, who
See Original Article